Atopic Diseases & Human Papilloma Virus
NCT04397081 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 239
Last updated 2020-05-26
Summary
Cervical cancer is an important health problem in women. Human papillomavirus (HPV) is considered the primary etiological agent of cervical cancer worldwide. Cervical cancer screening methods are proved one of the few screening methods that are thought to decrease invasive cancer incidence and mortality. In our country, HPV screening is carried out free of charge by public health to women between the ages of 30-65 aim is to compare HPV screening results between women diagnosed with atopic disease and healthy women without a history of atopy.If HPV is detected more frequently in patients with atopy, it may be recommended to follow more closely in vaccination and screening programs. Therefore, our study was designed to evaluate whether HPV positivity is common in atopic women.
Conditions
- Human Papilloma Virus
- Atopic Asthma
- Atopic Disorders
Interventions
- OTHER
-
HPV test results
The human papillomavirus (HPV) test detects the presence of the human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The procedure includes taking samples of your cervical cells using a soft brush and a flat scraping device called a spatula. This doesn't hurt, and you may not even feel the sample being taken.
Sponsors & Collaborators
-
Adana Numune Training and Research Hospital
lead OTHER_GOV
Principal Investigators
-
Gulsum Uysal · Adana City Education and Research Hospital
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-01
- Primary Completion
- 2020-02-29
- Completion
- 2020-03-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
NCT02634190 ·Status: COMPLETED
-
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
NCT01207999 ·Status: COMPLETED
-
HPV Self-test to Increase Cervical Cancer Screening in Asian Women
NCT04612660 ·Status: COMPLETED ·Phase: NA
-
Prevention and Screening Towards Elimination of Cervical Cancer
NCT05234112 ·Status: COMPLETED ·Phase: NA
-
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
NCT07077980 ·Status: NOT_YET_RECRUITING
-
Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV
NCT04587050 ·Status: COMPLETED
-
HPV Infections, Cancer of the Vulva and Therapeutical Success
NCT03082950 ·Status: COMPLETED
-
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
NCT00019110 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Cyberchondria Severity in the Relationship Between HPV Awareness and Vaccination Attitudes in Adult Women
NCT06800456 ·Status: COMPLETED
-
A Multicenter Cohort Study Assessing the Efficacy and Adverse Effects of HPV Vaccination in Chinese Women
NCT05932576 ·Status: UNKNOWN
-
Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV
NCT04974424 ·Status: UNKNOWN
-
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
NCT00002916 ·Status: COMPLETED ·Phase: PHASE2
-
Prevention of Cervical Cancer Through an HPV-based Screen-and-treat Strategy in Malawi
NCT04286243 ·Status: COMPLETED ·Phase: NA
-
HPV-based Screening Among Women 23-29 Years of Age
NCT05229679 ·Status: RECRUITING ·Phase: NA
-
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
NCT07033091 ·Status: RECRUITING ·Phase: NA
-
Comparing Strategies for Implementing Primary HPV Screening
NCT04371887 ·Status: UNKNOWN ·Phase: NA
-
ASPIRE Pilot: Comparing Self-collected HPV Testing With Visual Inspection With Acetic Acid Screening for Cervical Cancer
NCT02029794 ·Status: COMPLETED ·Phase: NA
-
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
NCT03178136 ·Status: UNKNOWN
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
NCT00481767 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia
NCT00931190 ·Status: COMPLETED
-
Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions
NCT02238990 ·Status: ACTIVE_NOT_RECRUITING
-
Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity
NCT01105000 ·Status: COMPLETED
-
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214 ·Status: COMPLETED
-
Men and Women Offering Understanding of Throat HPV
NCT03644563 ·Status: ACTIVE_NOT_RECRUITING
-
What is the Optimal Training Model for Cervical Awareness?
NCT06562595 ·Status: COMPLETED ·Phase: NA